|
|
||||||||
Departments of Nuclear Medicine and Medicine, Azienda Ospedaliera "Maggiore della Carità," Novara, Italy
Correspondence: For correspondence or reprints contact: Alberto Baroli, MD, Department of Nuclear Medicine, Azienda Ospedaliera "Maggiore della Carità," Corso Mazzini 18-28100 NOVARA, Italy.
ABSTRACT
The purpose of this study was to evaluate the feasibility of a shorter method of performing platelet kinetic studies with respect to the conventional 8-9-day approach. Methods: We studied 41 patients (28 women, 13 men; mean age 52 yr) with primary idiopathic trombocytopenic purpura (IIP) (n = 20), secondary IIP (n = 9), HCV associated thrombocytopenia (n = 9), splenectomy (n = 1) and hairy-cell leukemia (n = 1). The patients were in a steady-state of platelet turnover. Initial platelet counts ranged from 19 to 302 x 109/liter (mean value = 83). Platelet survival times (PST) were measured from the blood radioactivity disappearance curve of 111In-oxine-labeled autologus platelets following the recommendations of the International Committee for Standardization in Haematology: blood samples were taken at 30 min and 2 and 4 hr and thereafter daily for 7 days. PST was calculated by the weighted mean method and ranged from 18 to 219 hr (mean value = 98). PST was also calculated using only the data collected at 2,48 and 96 hr. If the radioactivity in the blood at 96 hr exceeded 10% of the 2-hr value, the additional point at 168 hr was used. Results: By using this reduced dataset, we obtained a correlation of r = 0.97 with the PST obtained from the whole dataset. In 24 patients, the difference was between ± 10 hr and exceeded 1 day in only 4. Conclusion: About 94% of the data may be recovered with only three or four blood samples and the duration may be shortened to 4 days in a significant proportion of patients (48% of ITP patients). This approach offers the advantages of increased patient throughput, compliance and reduced examination costs.
Key Words: platelet survival time indium-111-oxine agreement analysis
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |